Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 3, 2008, Pages 210-215

  Firuzi, Omidreza ^a,b   Spadaro, Antonio ^a   Spadaro, Chiara ^a   Riccieri, Valeria ^a   Petrucci, Rita ^a   Marrosu, Giancarlo ^a   Saso, Luciano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbonyl; Oxidative stress; Psoriatic arthritis; Sulfhydryl; Synovial fluid

Indexed keywords

C REACTIVE PROTEIN; CARBONYL DERIVATIVE; THIOL GROUP;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE; MALE; NEUTROPHIL; OSTEOARTHRITIS; OXIDATIVE STRESS; PATHOGENESIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEINS; SULFHYDRYL COMPOUNDS; SYNOVIAL FLUID;

EID: 44949242627     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20243     Document Type: Article

References (30)

1. Betteridge DJ. What is oxidative stress? Metabolism 2000;49:3-8.
2. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-278.
3. Mantle D, Falkous G, Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999;284:45-58.
4. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997;30:351-355.
5. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KL, Wolff SP. Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem J 1996;313:781-786.
6. Jain SK. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 1988;937:205-210.
7. Ozgunes H, Gurer H, Tuncer S. Correlation between serum malondialdehyde and ceruloplasmin activity values in rheumatoid arthritis. Clin Biochem 1995;28:193-194.
8. Selley ML, Bourne DJ, Bartlett MR, et al. Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1992;51:481-484.
9. Basu S, Whiteman M, Mattey DL, Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 2001;60:627-631.
10. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9-12.
11. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-478.
12. Korzon, M, Renke J, Popadiuk S, Wozniak M. Carbonyl content in plasma proteins of children with connective tissue inflammatory diseases. Pol J Environ Stud 1998;7:376-377.
13. Koster JF, Biemond P, Swaak AJ. Intracellular and extracellular sulfhydryl levels in rheumatoid arthritis. Ann Rheum Dis 1986;45:44-46.
14. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999;19:35-37.
15. Ambanelli U, Spisni A, Ferraccioli GF. Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulfhydrylant treatment. Scand J Rheumatol 1982;11:203-207.
16. Wade CR, Jackson PG, Highton J, van Rij AM. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis. Clin Chim Acta 1987;164:245-250.
17. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-1222.
18. Migita K, Yamasaki S, Kita M, et al. Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase-3. Immunology 2001;103:362-367.
19. Chapman ML, Rubin BR, Gracy RW. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1989;16:15-18.
20. Firuzi O, Fuksa L, Spadaro C, et al. Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 2006;58:951-957.
21. Dougados M, Van Der Linden S, Juhlin R; European Spondyloarthopathy Study Group: The European Spondyloarthopathy Study Group preliminary criteria for the classification of spondyloarthopathy. Arthritis Rheum 1991;34:1218-1227.
22. McGonagle D, Canaghan P, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999;42:1080-1086.
23. Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991;30:339-345.
24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
25. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:380-385.
26. Firuzi O, Giansanti L, Vento R, et al. Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines. J Pharm Pharmacol 2003;55:1021-1027.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
28. Macart M, Gerbaut L. An improvement of the Coomassie Blue dye binding method allowing an equal sensitivity to various proteins: application to cerebrospinal fluid. Clin Chim Acta 1982;122:93-101.
29. Wu SM, Pizzo SV. Alpha(2)-Macroglobulin from rheumatoid arthritis synovial fluid: functional analysis defines a role for oxidation in inflammation. Arch Biochem Biophys 2001;391:119-126.
30. Pruzanski W, Russell ML, Gordon DA, Ogryzlo MA. Serum and synovial fluid proteins in rheumatoid arthritis and degenerative joint diseases. Am J Med Sci 1973;265:483-490.